Also trades as: AJANTPHARM.BO (BSE) · $vol 0M

₹3,473.70 ($36.08)

-107.30 (-3.00%)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 57 · ₹448.0B mcap · 42M float · 0.270% daily turnover

Revenue

$54.5B +18.9% ▲

5Y CAGR: +13.9%

Gross Profit

$28.0B -18.9% ▼

5Y CAGR: +5.3%

Operating Income

$13.2B +17.4% ▲

5Y CAGR: +8.9%

Net Income

$10.6B +14.7% ▲

5Y CAGR: +10.1%

EPS (Diluted)

$84.53 +15.0% ▲

5Y CAGR: +11.0%

EBITDA

$15.7B +15.7% ▲

5Y CAGR: +8.9%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$32.8B	$37.4B	$42.1B	$46.5B	$54.5B
YoY Growth	+15.4%	+14.0%	+12.5%	+10.4%	+18.9%
Cost of Revenue	$8.9B	$11.1B	$11.2B	$10.7B	$26.5B
Gross Profit	$24.0B	$26.3B	$30.9B	$35.8B	$28.0B
Gross Margin	73.0%	70.3%	73.5%	77.0%	51.4%
R&D Expenses	$2.0B	$2.4B	$2.1B	$2.2B	$0
SG&A Expenses	$6.6B	$8.0B	$3.8B	$11.0B	$12.3B
Operating Expenses	$7.0B	$19.1B	$11.2B	$13.1B	$14.8B
Operating Income	$7.8B	$7.1B	$19.7B	$22.6B	$13.2B
Operating Margin	23.8%	19.0%	46.8%	48.7%	24.3%
Interest Expense	$102M	$58M	$72M	$207M	$161M
Income Before Tax	$9.1B	$7.5B	$11.1B	$11.9B	$13.8B
Tax Expense	$2.0B	$1.6B	$3.0B	$2.7B	$3.2B
Net Income	$7.1B	$5.9B	$8.2B	$9.2B	$10.6B
Net Margin	21.7%	15.7%	19.4%	19.8%	19.4%
EPS (Diluted)	$54.96	$45.89	$64.77	$73.53	$84.53
EBITDA	$10.4B	$8.8B	$12.6B	$12.7B	$15.7B
Shares Outstanding	130M	128M	126M	125M	125M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$11.4B	$11.9B	$11.5B	$11.1B	$13.0B	$13.5B	$13.7B	$14.2B
Cost of Revenue	$2.7B	$2.6B	$2.6B	$3.4B	$2.8B	$6.8B	$2.9B	$3.0B
Gross Profit	$8.8B	$9.2B	$8.9B	$7.7B	$10.3B	$6.8B	$10.9B	$11.2B
Gross Margin	76.6%	77.9%	77.5%	69.4%	78.8%	50.0%	79.2%	78.6%
R&D Expenses	$510M	$570M	$530M	$0	$0	$630M	$0	$0
SG&A Expenses	$2.1B	$3.0B	$2.5B	$2.9B	$3.0B	$2.9B	$3.1B	$0
Operating Expenses	$3.7B	$3.0B	$3.0B	$4.9B	$3.4B	$3.5B	$3.7B	$3.9B
Operating Income	$5.0B	$6.3B	$2.8B	$2.8B	$6.8B	$3.3B	$7.1B	$7.3B
Operating Margin	43.9%	53.1%	24.9%	25.6%	52.4%	24.1%	52.0%	51.4%
Interest Expense	$7M	$60M	$79M	$61M	$53M	$34M	$51M	$24M
Income Before Tax	$3.2B	$2.9B	$3.1B	$2.7B	$3.3B	$3.4B	$3.6B	$3.5B
Tax Expense	$764M	$738M	$745M	$442M	$758M	$806M	$848M	$804M
Net Income	$2.5B	$2.2B	$2.3B	$2.3B	$2.6B	$2.6B	$2.7B	$2.7B
Net Margin	21.5%	18.2%	20.3%	20.3%	19.6%	19.2%	19.9%	18.8%
EPS (Diluted)	$19.53	$17.26	$18.59	$18.04	$20.43	$20.82	$21.91	$21.35
EBITDA	$3.6B	$3.3B	$3.5B	$3.2B	$3.8B	$3.9B	$4.1B	$3.9B
Shares Outstanding	126M	125M	125M	125M	125M	125M	125M	125M

AJANTPHARM.NS NSE